Stock listing
Getein Biotech, Inc. Class A
Selected listing: 603387 · SSE · CNY · CN
Getein Biotech, Inc. Class A (Shanghai:603387), Health Technology. Latest release Sep 16, 2026: "Getein Biotech, Inc."Announcement on Outline of the 2026…
- Ticker
- Shanghai:603387
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- Shanghai
- Currency
- CNY
About Getein Biotech, Inc. Class A
Getein Biotech, Inc. Class A, trading under the ticker 603387, is a public company based in China. Its focus is on developing innovative solutions to improve healthcare outcomes.
Latest news from Getein Biotech, Inc. Class A
"Getein Biotech, Inc."Announcement on Outline of the 2026 Semi-annual Online Performance Briefing
September 15, 2026
"Getein Biotech, Inc."Announcement on Adjustment of Upper Limit of Repurchase Price Following Implementation of Dividend Distribution for the First Half of 2026
September 11, 2026
"Getein Biotech, Inc."Announcement on Obtaining a Commitment Letter for a Special Loan for Share Repurchase from a Financial Institution
August 31, 2026
"Getein Biotech, Inc."Announcement on Resolutions of the 14th Meeting of the 4th Board of Directors
August 26, 2026
"Getein Biotech, Inc."Announcement on Progress in Repurchasing Shares through Call Auction
August 3, 2026
Research Getein Biotech, Inc. Class A
Getein Biotech, Inc. Class A company profile
View the public company page for Getein Biotech, Inc. Class A on 6ix.
Getein Biotech, Inc. Class A news
Read company news and market updates connected to Getein Biotech, Inc. Class A.
Getein Biotech, Inc. Class A investor events
Find investor webinars, events, and replay context for Getein Biotech, Inc. Class A.